UCSF offers cautious recap but equates surrogate markers with clinical outcomes in MS drug study
NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations
Do statistically insignificant outcomes in multiple sclerosis treatment study deserve a news release?
Ottawa Hospital release on MS therapy hits the right notes with clarity and cautions
Data absent from claim that video game benefits MS patients
Engaging UCLA release suggests pregnancy hormone may benefit MS patients – but lacks key data
Exaggeration at the NIH? Mouse study release may go too far in suggesting “reversal” of multiple sclerosis